Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) has announced its consolidated financial statement through the Stock Exchange of Thailand as follows;
| Quarter | 2Q22 | 2Q21 |
| Net Profit (Loss) Million Baht |
2,664 | 1,452 |
| Earning Per Share (Baht) |
0.17 | 0.09 |
| % Change | 83 | |
| 6 Months | 2022 | 2021 |
| Net Profit (Loss) Million Baht |
6,107 | 2,791 |
| Earning Per Share (Baht) | 0.38 | 0.18 |
| % Change | 119 | |
In 2Q22, BDMS reported a net profit of Baht 2,664 million, increased by 83% YoY due to higher operating income and continued cost saving program.
The company had consolidated operating income of Baht 21,981 million, an increase of 26% from 2Q21. Key drivers were from higher hospital revenues of 18% YoY from Thai patients and 69% YoY from international patients. The key growth drivers for Thai patient revenues were from a return of non COVID-19 patients. In terms of international patient revenues, the strong growth was from a recovery of fly-in patients. These supporting factors helped increase the overall occupancy rate from 60% in 2Q21 to 69% in 2Q22.
Meanwhile, net profit for six-month period ended 30 June was Baht 6,107 million, increased by 119% YoY.
